SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-028205
Filing Date
2022-08-04
Accepted
2022-08-04 16:19:19
Documents
15
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10040239_8k.htm   iXBRL 8-K 26332
2 EXHIBIT 99.1 brhc10040239_ex99-1.htm EX-99.1 252054
6 image0.jpg GRAPHIC 32875
7 image00001.jpg GRAPHIC 3425
  Complete submission text file 0001140361-22-028205.txt   520350

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cemi-20220804.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20220804_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20220804_pre.xml EX-101.PRE 16042
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040239_8k_htm.xml XML 4053
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 221136884
SIC: 2834 Pharmaceutical Preparations